Market entry in France completed
|
EQS-News: innoscripta SE
/ Key word(s): Expansion
innoscripta drives expansion in Europe: Market entry in France completed Munich, April 15, 2026 – innoscripta SE (“innoscripta”, ISIN: DE000A40QVM8) continues to execute its European growth strategy and has expanded into France. The company is addressing the attractive French market with a newly opened location in Toulouse, led by an experienced industry expert. In this context, innoscripta has started to build a high-caliber sales team on site. France represents a key European market for tax incentives, particularly due to the government-supported CIR (Crédit d’Impôt Recherche) program, which is currently around six times larger in volume than the German R&D tax incentive. The program allows companies to claim tax credits for their research and development (R&D) expenditures. Each year, incentives amounting to billions of euros are made available to companies in France. According to market studies, R&D spending across OECD countries is expected to grow by 7% annually until 2030, with total gross domestic R&D expenditure currently at approximately EUR 1.9 trillion. France itself invests around 2.2% of its GDP in R&D and ranks third in Europe—after Germany and the United Kingdom—and among the top ten globally. The expansion into France focuses on the full rollout of the all-in-one platform Clusterix for French customers. The platform enables companies to structure, document, manage, and scale their R&D activities more efficiently and transparently. Toulouse is considered one of Europe’s leading innovation hubs, with a high concentration of research-intensive companies in sectors such as aerospace and deep tech. Sebastian Schwertlein, COO of innoscripta: In addition to France, innoscripta plans to expand into further European and international markets in the coming months. About innoscripta Contact Details Press Contact
15.04.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | innoscripta SE |
| Arnulfstraße 60 | |
| 80335 München | |
| Germany | |
| Phone: | +4989262004187 |
| E-mail: | info@innoscripta.com |
| Internet: | https://www.innoscripta.com |
| ISIN: | DE000A40QVM8 |
| WKN: | A40QVM |
| Listed: | Regulated Unofficial Market in Frankfurt (Scale) |
| EQS News ID: | 2308520 |
| End of News | EQS News Service |
|
|
2308520 15.04.2026 CET/CEST

